Qushi Huoxue ointment ameliorates metabolic associated steatotic liver disease through autophagy activation and ferroptosis inhibition

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 2

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Hepatol. Feb 27, 2026; 18(2): 115763
Published online Feb 27, 2026. doi: 10.4254/wjh.v18.i2.115763

Table 1 Quantitative real-time polymerase chain reaction primer sequence list

GPX4: Glutathione peroxidase 4.

Citation: Liu YY, Qin H, Wu HX, Wang RT, Yang QY, Jiang F, Liu XD, Wu DK, Tang YM. Qushi Huoxue ointment ameliorates metabolic associated steatotic liver disease through autophagy activation and ferroptosis inhibition. World J Hepatol 2026; 18(2): 115763
URL: https://www.wjgnet.com/1948-5182/full/v18/i2/115763.htm
DOI: https://dx.doi.org/10.4254/wjh.v18.i2.115763

Liu YY, Qin H, Wu HX, Wang RT, Yang QY, Jiang F, Liu XD, Wu DK, Tang YM. Qushi Huoxue ointment ameliorates metabolic associated steatotic liver disease through autophagy activation and ferroptosis inhibition. World J Hepatol 2026; 18(2): 115763 [PMID: 41809478 DOI: 10.4254/wjh.v18.i2.115763]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.